Artículo

Estamos trabajando para incorporar este artículo al repositorio
Consulte la política de Acceso Abierto del editor

Abstract:

The MHC class I chain-related protein A (MICA) is an inducible molecule almost not expressed by normal cells but strongly up-regulated in tumor cells. MICA-expressing cells are recognized by natural killer (NK) cells, CD8 + αβTCR and γδTCR T lymphocytes through the NKG2D receptor. Engagement of NKG2D by MICA triggers IFN-γ secretion and cytotoxicity against malignant cells. Although most solid tumors express MICA and this molecule is a target during immune surveillance against tumors, it has been observed that high grade tumors from different histotypes express low amounts of cell surface MICA due to a metalloprotease-induced shedding. Also, melanomas develop after a complex process of neotransformation of normal melanocytes. However, the expression of MICA in premalignant stages (primary human quiescent melanocytic nevi) remains unknown. Here, we assessed expression of MICA by flow cytometry using cell suspensions from 15 primary nevi isolated from 11 patients. When collected material was abundant, cell lysates were prepared and MICA expression was also analyzed by Western blot. We observed that MICA was undetectable in the 15 primary nevi (intradermic, junction, mixed, lentigo and congenital samples) as well as in normal skin, benign lesions (seborrheic keratosis), premalignant lesions (actinic keratosis) and benign basocellular cancer. Conversely, a primary recently diagnosed melanoma showed intense cell surface MICA. We conclude that the onset of MICA expression is a tightly regulated process that occurs after melanocytes trespass the stage of malignant transformation. Thus, analysis of MICA expression in tissue sections of skin samples may constitute a useful marker to differentiate between benign and malignant nevi.

Registro:

Documento: Artículo
Título:Premalignant quiescent melanocytic nevi do not express the MHC class i chain-related protein A
Autor:Fuertes, M.B.; Rossi, L.E.; Peralta, C.M.; Cabrera, H.N.; Allevato, M.A.; Zwirner, N.W.
Filiación:Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina
Departamento de Dermatología, Hospital de Clínicas José de San Martín, Argentina
Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Argentina
Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina
Palabras clave:Melanoma; MICA; Skin; major histocompatibility antigen class 1; protein A; actinic keratosis; article; basal cell carcinoma; cancer staging; cell lysate; cell suspension; clinical article; flow cytometry; human; human tissue; malignant transformation; melanocytic nevus; melanoma; protein expression; seborrheic keratosis; Western blotting; Flow Cytometry; Histocompatibility Antigens Class I; Humans; Nevus; Precancerous Conditions; Skin Neoplasms
Año:2011
Volumen:71
Número:4
Página de inicio:357
Página de fin:360
Título revista:Medicina
Título revista abreviado:Medicina (Argentina)
ISSN:00257680
CODEN:MEDCA
CAS:Histocompatibility Antigens Class I; MHC class I-related chain A
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v71_n4_p357_Fuertes

Referencias:

  • Dunn, G.P., Old, L.J., Schreiber, R.D., The immunobiology of cancer immunosurveillance and immunoediting (2004) Immunity, 21, pp. 137-148
  • Burgess, S.J., Maasho, K., Masilamani, M., Narayanan, S., Borrego, F., Coligan, J.E., The NKG2D receptor: Immunobiology and clinical implications (2008) Immunol Res, 40, pp. 18-34
  • Zwirner, N.W., Fuertes, M.B., Girart, M.V., Domaica, C.I., Rossi, L.E., Cytokine-driven regulation of NK cell functions in tumor immunity: Role of the MICA-NKG2D system (2007) Cytokine & Growth Factor Rev, 18, pp. 159-170
  • G roh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K.H., Spies, T., Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB (1999) Proc Natl Acad Sci USA, 96, pp. 6879-6884
  • V etter, C.S., Groh, V., thor Straten, P., Spies, T., Brocker, E.B., Becker, J.C., Expression of stress-induced MHC class I related chain molecules on human melanoma (2002) J Invest Dermatol, 118, pp. 600-605
  • G asser, S., Orsulic, S., Brown, E.J., Raulet, D.H., The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor (2005) Nature, 436, pp. 1186-1190
  • S tern-Ginossar, N., Gur, C., Biton, M., Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D (2008) Nat Immunol, 9, pp. 1065-1073
  • T ang, K.F., Ren, H., Cao, J., Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB (2008) J Cell Biol, 182, pp. 233-239
  • U nni, A.M., Bondar, T., Medzhitov, R., Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance (2008) Proc Natl Acad Sci USA, 105, pp. 1686-1691
  • Molinero, L.L., Fuertes, M.B., Girart, M.V., NF-kappaB regulates expression of the MHC Class I-related Chain A Gene in activated T lymphocytes (2004) J Immunol, 173, pp. 5583-5590
  • Watson, N.F., Spendlove, I., Madjd, Z., Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients (2006) Int J Cancer, 118, pp. 1445-1452
  • S alih, H.R., Rammensee, H.-G., Steinle, A., Down-Regulation of MICA on Human Tumors by Proteolytic Shedding (2002) J Immunol, 169, pp. 4098-4102
  • Waldhauer, I., Goehlsdorf, D., Gieseke, F., Tumorassociated MICA is shed by ADAM proteases (2008) Cancer Res, 68, pp. 6368-6376
  • Fuertes, M.B., Girart, M.V., Molinero, L.L., Intracellular retention of the NKG2D Ligand MHC Class I Chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity (2008) J Immunol, 180, pp. 4606-4614
  • Wick, M.R., Patterson, J.W., Cutaneous melanocytic lesions: Selected problem areas (2005) Am J Clin Pathol, 124, pp. S52-S83

Citas:

---------- APA ----------
Fuertes, M.B., Rossi, L.E., Peralta, C.M., Cabrera, H.N., Allevato, M.A. & Zwirner, N.W. (2011) . Premalignant quiescent melanocytic nevi do not express the MHC class i chain-related protein A . Medicina, 71(4), 357-360.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v71_n4_p357_Fuertes [ ]
---------- CHICAGO ----------
Fuertes, M.B., Rossi, L.E., Peralta, C.M., Cabrera, H.N., Allevato, M.A., Zwirner, N.W. "Premalignant quiescent melanocytic nevi do not express the MHC class i chain-related protein A " . Medicina 71, no. 4 (2011) : 357-360.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v71_n4_p357_Fuertes [ ]
---------- MLA ----------
Fuertes, M.B., Rossi, L.E., Peralta, C.M., Cabrera, H.N., Allevato, M.A., Zwirner, N.W. "Premalignant quiescent melanocytic nevi do not express the MHC class i chain-related protein A " . Medicina, vol. 71, no. 4, 2011, pp. 357-360.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v71_n4_p357_Fuertes [ ]
---------- VANCOUVER ----------
Fuertes, M.B., Rossi, L.E., Peralta, C.M., Cabrera, H.N., Allevato, M.A., Zwirner, N.W. Premalignant quiescent melanocytic nevi do not express the MHC class i chain-related protein A . Medicina (Argentina). 2011;71(4):357-360.
Available from: https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v71_n4_p357_Fuertes [ ]